Status:

UNKNOWN

Cost-effectiveness of the Influenza Vaccination

Lead Sponsor:

International Centre for Diarrhoeal Disease Research, Bangladesh

Collaborating Sponsors:

Centers for Disease Control and Prevention

Institute of Epidemiology, Disease Control and Research

Conditions:

Influenza Vaccine

Cost-Effectiveness

Eligibility:

All Genders

6+ years

Phase:

PHASE4

Brief Summary

Background: In Bangladesh, seasonal influenza imposes considerable health and economic burden, particularly for those at high risk of severe disease. To prevent influenza and lessen the economic burde...

Detailed Description

Background: Globally, seasonal influenza is a leading cause of morbidity and mortality with significant health and economic consequences. According to the World Health Organization (WHO), influenza af...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Participants who will be visiting study hospitals (outpatients and inpatients only. Not emergency departments) for routine care during the study period.
  • Participants who will be children six months to 8 years or aged more than 60 years or pregnant ( any trimester), or have any chronic disease
  • Participants /parents/caregivers who will be willing to sign the informed consent form.
  • Exclusion criteria:
  • Participants with severe, life-threatening allergies to any ingredient in a flu vaccine (other than egg proteins)
  • Participants having history of a severe allergic reaction (e.g., anaphylaxis) after a previous dose of influenza vaccine or to a vaccine component
  • Participants having a history of guillain-barre syndrome less than 6 weeks after a previous dose of influenza vaccine
  • Participants having history of moderate or severe acute illness with or without fever. The vaccine should be given after the acute condition has improved.

Exclusion

    Key Trial Info

    Start Date :

    September 29 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2024

    Estimated Enrollment :

    2567 Patients enrolled

    Trial Details

    Trial ID

    NCT05996549

    Start Date

    September 29 2022

    End Date

    September 30 2024

    Last Update

    August 18 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Rajshahi Medical College Hospital

    Rajshahi, Bangladesh, 6000